When caught at stage 1, epithelial ovarian cancer has a five-year survival rate as high as 93%. But for over 70% of patients, the cancer has already spread beyond the pelvis at diagnosis. Despite aggressive treatment, the five-year survival drops to 23–41% at stage 3 and just 5–11% at stage 4.